Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells

OBJECTIVES: Therapeutic potential of conventionally used platinum‐based drugs in treatment of colorectal tumours has been limited due to high incidence of tumour resistance to them and to their severe side effects. This evokes a search for more suitable anti‐cancer drugs. We have compared ability of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Prolif
Asıl Yazarlar: Vondálová Blanářová, O., Jelínková, I., Hyršlová Vaculová, A., Sova, P., Hofmanová, J., Kozubík, A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2013
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496914/
https://ncbi.nlm.nih.gov/pubmed/24118195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12061
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller